Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη του ενδιάμεσου μεταβολισμού σε παιδιά με οξεία λεμφοβλαστική λευχαιμία

Abstract

dc:description

Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Despite major improvements in survival rates through risk-adapted treatment protocols based on molecular stratification, relapse and treatment resistance remain significant causes of morbidity and mortality. Metabolomics, the comprehensive study of low-molecular-weight metabolites in biological systems, provides a functional snapshot of cellular activity and may improve our understanding of leukemia biology. The aim of this study was to investigate metabolic alterations in children with ALL, compare their metabolic profiles with those of controls, and assess metabolic changes at diagnosis and after remission induction therapy. This prospective case-control study included thirty-four children aged one to sixteen years with newly diagnosed ALL and thirty four age- and sex-matched controls without malignant or inflammatory disease. Blood and urine samples were collected after overnight fasting at diagnosis and at the end of induction therapy for patients’ group. Targeted metabolomic analysis was performed using GC-MS and LC-MS/MS for the quantitative assessment of amino acids, fatty acids, acylcarnitines, and organic acids. The results demonstrated a distinct metabolic profile in children with ALL that was already evident at diagnosis. Patients exhibited increased levels of saturated and unsaturated fatty acids, carnitine, and short-chain acylcarnitines, together with decreased concentrations of several amino acids and organic acids involved in cellular biosynthesis and energy metabolism. Metabolic differences were also observed among disease subtypes, suggesting underlying biological heterogeneity. Although some metabolic abnormalities were attenuated following induction therapy, the metabolic profile remained clearly different from that of controls despite clinical remission. These findings indicate extensive metabolic reprogramming involving lipid metabolism, amino acid metabolism, and energy pathways in pediatric ALL. The observed alterations are consistent with adaptive mechanisms that support leukemic cell proliferation and survival. Furthermore, preliminary evidence suggests that the metabolic signature may be associated with relapse and treatment resistance. If further confirmed, metabolic fingerprint may therefore contribute to improved disease characterization, identification of novel prognostic biomarkers, and development of targeted therapeutic strategies in pediatric ALL.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papadopoulou, Maria
  • Παπαδοπούλου, Μαρία

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60917

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papadopoulou, Maria; Παπαδοπούλου, Μαρία. Μελέτη του ενδιάμεσου μεταβολισμού σε παιδιά με οξεία λεμφοβλαστική λευχαιμία. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/60917